TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 4.10.
| Share Price | ₹391.2 | Oct 07,2026 |
| Market Cap | ₹469.4 Cr | |
| Sales-TTM | ₹114.4 Cr | TTM-Consolidated Results |
| Price/Sales | 4.10x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹469.4 Cr] as on Oct 07,2026
(/) Sales [ ₹114.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.10x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '4.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.35x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 4.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TRIDENT LIFELINE | 114.4 | 4.10 | 469.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.14 | 427,861.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.65 | 254,319.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.39 | 179,153.0 |
| CIPLA LTD | 28,324.4 | 3.79 | 107,406.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.02 | 100,362.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.99 | 103,049.0 |
| LUPIN LTD | 29,966.6 | 3.06 | 91,782.7 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.03 | 115,112.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.78 | 96,951.2 |
| LAURUS LABS LTD | 7,269.6 | 15.27 | 111,034.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.78x |
| Max industry PS | 22.65x |
| Median industry PS | 4.10x |
| Average industry PS | 7.66x |
You may also like the below Video Courses